Compounds > metopimazine
Page last updated: 2024-08-22

metopimazine and Benign Neoplasms

metopimazine has been researched along with Benign Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bloch, J; Delgado, A; Khayat, D; Meric, JB; Rixe, O1
Bensaoula, O; Bethune-Volters, A; Chidiac, J; Delgado, A; Di Palma, M; Khamales, S1
Dombernowsky, P; Handberg, J; Hansen, M; Herrstedt, J; Schousboe, BM; Sigsgaard, T1
d'Allens, H; Depierre, A; Giovannini, M; Hédouin, M; Kaluzinski, L; Lebeau, B; Rivière, A; Votan, B1
Israel, L; Rodary, C1

Trials

5 trial(s) available for metopimazine and Benign Neoplasms

ArticleYear
Comparison of the efficacy and safety of combinations of metopimazine or ondansetron with methylprednisolone in the prevention of delayed emesis in patients receiving chemotherapy.
    Current medical research and opinion, 2005, Volume: 21, Issue:11

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Isonipecotic Acids; Male; Methylprednisolone; Middle Aged; Nausea; Neoplasms; Ondansetron; Quality of Life; Surveys and Questionnaires; Vomiting

2005
A randomized, double-blind trial assessing the efficacy and safety of sublingual metopimazine and ondansetron in the prophylaxis of chemotherapy-induced delayed emesis.
    Anti-cancer drugs, 2006, Volume: 17, Issue:2

    Topics: Administration, Sublingual; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isonipecotic Acids; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neoplasms; Ondansetron; Quality of Life; Surveys and Questionnaires; Vomiting

2006
Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:4

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Carboplatin; Cisplatin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isonipecotic Acids; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Platinum Compounds; Severity of Illness Index; Treatment Outcome; Vomiting

1997
The efficacy of a combination of ondansetron, methylprednisolone and metopimazine in patients previously uncontrolled with a dual antiemetic treatment in cisplatin-based chemotherapy. The French Ondansetron Study Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:9

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Double-Blind Method; Drug Therapy, Combination; Humans; Isonipecotic Acids; Methylprednisolone; Middle Aged; Nausea; Neoplasms; Ondansetron; Prognosis; Quality of Life; Vomiting

1997
Treatment of nausea and vomiting related to anti-cancerous multiple combination chemotherapy: results of two controlled studies.
    The Journal of international medical research, 1978, Volume: 6, Issue:3

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Isonipecotic Acids; Male; Middle Aged; Nausea; Neoplasms; Phenothiazines; Placebos; Vomiting

1978